Browse Category

NASDAQ:SXTC News 9 January 2026

China SXT Pharmaceuticals (SXTC) stock whipsaws after AI “clinics” plan, with Friday open in focus

China SXT Pharmaceuticals (SXTC) stock whipsaws after AI “clinics” plan, with Friday open in focus

New York, Jan 9, 2026, 06:19 EST — Premarket China SXT Pharmaceuticals Inc shares ended Thursday down 37.5% at $1.25 after swinging between $1.21 and $6.98, with volume jumping to about 109.3 million shares, Yahoo Finance data showed. The day before, the stock closed at $2.00 on roughly 115,000 shares. (Yahoo Finance) The China-based maker of traditional Chinese medicine products…

Stock Market Today

  • AngloGold Ashanti's Strong Earnings Growth Draws Investor Interest
    January 31, 2026, 7:55 AM EST. AngloGold Ashanti (NYSE:AU) reported a striking rise in earnings per share (EPS), jumping from $1.34 to $4.46 in a year, signaling solid profit growth. The company's earnings before interest and tax (EBIT) margins expanded from 26% to 40%, alongside increasing revenues, indicating improved operational efficiency. With a market capitalization near $54 billion, insiders hold around $42 million in shares, reflecting significant personal investment. While past performance is promising, analysts caution investors to assess if this growth is sustainable or a one-time spike. AngloGold Ashanti's financial health and profitable metrics may appeal to investors seeking companies with consistent earnings rather than high-risk ventures.
Go toTop